BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 66 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,147,353 | -20.0% | 357,207 | -8.8% | 0.45% | -13.4% |
| Q2 2023 | $6,437,608 | -3.4% | 391,582 | -1.9% | 0.52% | +2.2% |
| Q1 2023 | $6,662,331 | +5.5% | 399,181 | -2.3% | 0.51% | +0.4% |
| Q4 2022 | $6,312,557 | +7.2% | 408,712 | +3.4% | 0.51% | -1.0% |
| Q3 2022 | $5,890,000 | +6.3% | 395,188 | +16.9% | 0.51% | +29.2% |
| Q2 2022 | $5,542,000 | +26.6% | 337,938 | +54.7% | 0.40% | +43.8% |
| Q1 2022 | $4,376,000 | +15.3% | 218,424 | +45.6% | 0.28% | +29.0% |
| Q4 2021 | $3,795,000 | +39.4% | 149,972 | +48.6% | 0.21% | +31.3% |
| Q3 2021 | $2,722,000 | -24.2% | 100,933 | -18.8% | 0.16% | -12.8% |
| Q2 2021 | $3,589,000 | +36.4% | 124,311 | +24.0% | 0.19% | +29.0% |
| Q1 2021 | $2,631,000 | +544.9% | 100,211 | +605.4% | 0.14% | +504.2% |
| Q4 2020 | $408,000 | -36.7% | 14,207 | -47.4% | 0.02% | -50.0% |
| Q3 2020 | $645,000 | +10.8% | 27,007 | -3.2% | 0.05% | +6.7% |
| Q2 2020 | $582,000 | – | 27,907 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |